Engflag

Tetran-Hydrocortison

Quick links to important sections

Tetran-Hydrocortison

Tetran-Hydrocortison_EN

Method of action: Antiallergic, Anti-Inflammatory, Antipruritic

Treatment option: Atopic Dermatitis, Dermatitis, Intertriginous Dermatitis, Eczema

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Tetran-Hydrocortison

What is Tetran-Hydrocortison? (Foundational Overview)

Property Description
Active Ingredient Hydrocortisone, Oxytetracycline hydrochloride
Form Topical Ointment or Cream
Pharmacological Class Topical Corticosteroid and Antibiotic Combination
General Purpose Dual anti-inflammatory and anti-bacterial action
Origin Semi-synthetic

What is the Drug Class and Form of Tetran-Hydrocortison?

Tetran-Hydrocortison is defined as a fixed-dose combination drug, which is a clinically recognized pharmaceutical strategy for simultaneously addressing multiple aspects of a condition. Pharmacologically, it is classed as a topical corticosteroid and antibiotic combination. The preparation is intended exclusively for topical administration, meaning it is used locally on the affected area. It is typically supplied as either a stable topical ointment or a cream, reflecting standard forms used for treating skin conditions that benefit from focused, surface-level application.

What is Tetran-Hydrocortison Composed of?

The medicine derives its activity from its two main active ingredients: Hydrocortisone and Oxytetracycline hydrochloride. Hydrocortisone functions as the glucocorticoid component, which is utilized for its effectiveness in suppressing localized inflammation. Oxytetracycline, a member of the tetracycline antibiotic class, works by inhibiting the growth and reproduction of susceptible bacteria, often referred to as a broad-spectrum agent. This composition ensures comprehensive action against both inflammation and microbial presence.

What is the General Purpose of Combining these Two Ingredients?

The primary general purpose of this combined formulation is to achieve an efficient dual anti-inflammatory and anti-bacterial action. The formulation is designed to rapidly mitigate the disruptive symptoms of inflammation, such as swelling, redness, and itching, while the antibiotic component controls the proliferation of bacteria. This therapeutic approach is a trusted method for the local management of conditions where inflammation and a superficial bacterial infection coexist.

Regulatory References

  1. Hydrocortisone Monograph
  2. EMA Combination Products Guidance

What side effects are possible with Tetran-Hydrocortison?

Possible Side Effects and Safety Information

This section summarizes documented adverse reactions and safety considerations for Tetran-Hydrocortison, primarily based on governmental regulatory documents.

Adverse Reaction Profile

Adverse reactions associated with the corticosteroid component of Tetran-Hydrocortison span multiple system-organ classes, including Fluid and Electrolyte Disturbances, Musculoskeletal, Gastrointestinal, Dermatologic, and Neurological/Psychiatric systems.

Serious and Clinically Significant Adverse Reactions may include Anaphylaxis and other severe allergic reactions, Adrenocortical insufficiency upon abrupt cessation after prolonged use, and an increased risk of severe or fatal infections (including opportunistic infections and reactivation of latent diseases). Other serious risks are Peptic Ulcer with possible perforation and hemorrhage and Ophthalmic effects (e.g., glaucoma, posterior subcapsular cataracts).

Dose- and Exposure-Related Patterns: The risk of many adverse effects, such as HPA axis suppression, osteoporosis, and slowed growth and development in pediatric populations, is generally correlated with the duration of use and the dose level.

Safety Restrictions and Monitoring

The medication is contraindicated in patients with known systemic fungal infections. Administration of live or live, attenuated vaccines is generally not recommended when receiving immunosuppressive doses of the drug.

Use requires caution in patients with certain pre-existing conditions, including ocular herpes simplex, active or latent tuberculosis, diabetes, hypertension, peptic ulcer, and significant psychiatric instability.

Official labeling emphasizes that corticosteroids may mask some signs of infection, and the lowest possible effective dosage should be used to minimize the risk of serious side effects.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose of Tetran-Hydrocortison, a corticosteroid, is primarily associated with acute or chronic exposure to excessive amounts of the medication. Immediate medical attention is required if an overdose is suspected. Call the local emergency number (such as 911) or a poison control center (e.g., 1-800-222-1222) immediately; do not delay calling for help.

Documented Overdose Presentations

Official regulatory information describes potential manifestations of corticosteroid overdose, which can affect the central nervous system, cardiovascular system, and fluid/electrolyte balance. Symptom clusters may include:

  • Altered mental status (such as agitation or psychosis)
  • Convulsions (seizures)
  • Heart rhythm disturbances (e.g., rapid or irregular pulse)
  • High blood pressure
  • Nausea and vomiting

Most cases result in minor, transient changes in body fluids and electrolytes. However, the event is classified as more serious if heart rhythm disturbances occur.

Emergency Actions Required

Upon seeking medical help, the provider will measure and monitor vital signs (temperature, pulse, breathing rate, and blood pressure). Procedural instructions for overdose situations may involve specific tests and treatments, including: blood and urine tests, Chest X-ray, ECG (electrocardiogram), and the administration of Activated Charcoal.

Connection to the overall overdose profile: Regulatory documents define the overdose profile as a risk following acute or chronic overexposure, with potential for serious cardiovascular and neurological manifestations. The critical guidance is the immediate contact of emergency services to initiate supportive monitoring and treatment, which is consistent with the general management of acute medication overdose.

Therapeutic Uses of Tetran-Hydrocortison

What Tetran-Hydrocortison Treats: Main Uses and Benefits

Tetran-Hydrocortison is commonly used as a combined anti-inflammatory and anti-bacterial therapy, relevant for localized skin issues where inflammation and a superficial bacterial infection coexist. This therapeutic combination is utilized in situations involving such mixed-pathology conditions to address both components simultaneously.

Key Therapeutic Applications

This medication is generally applied in addressing conditions characterized by episodic or fluctuating symptom patterns where a secondary infection is present alongside the inflammation. It is relevant across various dermatological contexts, including infected eczema, allergic dermatitis, seborrhoeic dermatitis, and acutely inflamed, secondarily infected insect bite reactions. The product is applied in addressing symptom clusters that may become intense or disruptive, primarily itching (pruritus), significant redness (erythema), and localized swelling.

Symptomatic Benefit and Context of Use

It is relevant in clinical settings marked by increased discomfort or tension, and often provides symptomatic relief that may help patients cope more steadily with symptom fluctuations. It is applied in contexts where additional symptomatic support is needed, such as in managing acute flare-ups of flexural intertrigo (inflammation in skin folds). By easing the visible and irritating manifestations, the medication contributes to improved comfort and assists with maintaining functional stability during episodes of sudden symptom escalation.

Quick Fact: Relief for Dual Pathology This product is relevant for managing both the inflammation and the superficial bacterial component at the same time, contributing to easing the overall symptom load.

Eligibility and Restrictions for Use

The eligibility for using Tetran-Hydrocortison (Oxytetracycline/Hydrocortisone topical combination) is strictly defined by regulatory authorities based on age, physiological status, and the type of skin condition present.

Populations Who Must Not Use This Medicine

The medicine is contra-indicated for several specific groups and conditions, as stated in official labeling:

  • Hypersensitivity: Individuals with a known allergy to Hydrocortisone, Oxytetracycline, or any other ingredient.
  • Infants and Small Children: Use is prohibited due to the theoretical risk of damage to permanent dentition from the tetracycline component.
  • Pregnancy and Lactation: Use is contra-indicated in pregnant women and nursing mothers for the same dental risk noted above.
  • Primary Infections: It is contra-indicated for treating primary bacterial infections of the skin, such as impetigo or furunculosis.

Age and Condition-Specific Eligibility

Age Group / Condition Regulatory Eligibility Status
Children (General) Use is not recommended
Older Adults / Elderly No special precautions required
Renal or Hepatic Impairment No special precautions required

Eligibility is confirmed for adults, including the elderly, and regulatory guidance confirms no special precautions are necessary for patients with impaired kidney or liver function.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information regarding the interaction profile for Tetran-Hydrocortison is based on the potential for minimal systemic exposure from its active components, Hydrocortisone (corticosteroid) and Oxytetracycline (tetracycline antibiotic).

Documented Pharmacological Interactions

Category Interacting Substances and Formal Restriction
Exposure Modification Co-administration of the oxytetracycline component with oral Anticoagulants (e.g., Warfarin) is documented to increase their activity.
Pharmacodynamic Risk The combination of the oxytetracycline component with Retinoids is formally documented to increase the risk of pseudotumor cerebri.
Contraindicated Class The corticosteroid component restricts concurrent use with live or live, attenuated vaccines in patients receiving immunosuppressive doses.

Interactions with Supplements and Specific Populations

Interference with the oxytetracycline component's absorption is a key consideration. Products containing divalent or trivalent cations (e.g., Aluminum, Calcium, Iron, Magnesium, Zinc), often found in supplements or antacids, may reduce the systemic absorption of oxytetracycline due to chelation. For this reason, regulatory documents for the antibiotic class require timing separation. Additionally, an enhanced effect of the corticosteroid component is noted in patients with underlying conditions such as Hypothyroidism or Cirrhosis.

Mechanism of Action

Tetran-Hydrocortison utilizes a dual mechanism to modulate key biological processes simultaneously at the site of application.

Modulation of Inflammatory Gene Expression

The Hydrocortisone component acts as an agonist on the Glucocorticoid Receptor ( GRalpha). This molecular interaction regulates the transcription of genetic material, resulting in the suppression of pro-inflammatory signaling factors and the upregulation of anti-inflammatory proteins like Lipocortin-1. This intervention at the genomic level limits the production of inflammatory mediators such as prostaglandins and leukotrienes, leading to reduced capillary permeability and decreased extravasation of fluid.

Inhibition of Bacterial Protein Synthesis

The Oxytetracycline component exerts its action by specifically targeting the bacterial 30S ribosomal subunit. By binding to this crucial structure, the drug physically blocks the process of protein translation, arresting the bacteria's ability to construct new proteins essential for growth and replication. This bacteriostatic effect contributes to the arrest of microbial proliferation.

Complementary Pathway Synergy

The mechanisms are mechanistically complementary: Hydrocortisone modulates the host's localized immune response by dampening the immune signaling cascade, while Oxytetracycline targets the local bacterial population by inhibiting its cellular machinery. This combined approach achieves coordination between anti-inflammatory and anti-proliferative mechanisms.

Dosage and Administration Information

How to Use Tetran-Hydrocortison: Administration Guidelines

This section describes the administration and dosing instructions for Tetran-Hydrocortison (Oxytetracycline/Hydrocortisone).

Administration Details

Feature Instruction
Route of Administration Topical (External use only on the skin)
Dosing Schedule Apply a small amount to the affected area, forming a thin layer.
Frequency Two to four times daily

Use Protocol and Special Conditions

Tetran-Hydrocortison is structured for short-term use and is applied according to specific procedural steps.

Key Procedural Steps and Constraints:

  • Preparation: The affected skin area should be cleaned as thoroughly as possible before application.
  • Duration: The maximum recommended treatment course is not more than seven days. If no clinical improvement is observed within this time, use is discontinued, and the patient's condition is re-evaluated.
  • Occlusion: The treated area must not be bandaged, covered, or wrapped (occlusive dressing) unless specifically directed by a healthcare professional, due to the hydrocortisone component.
  • Exclusions: The product is strictly for external use and must not be used for eye infections.

The entirety of these instructions defines the standardized, short-course approach to using this combination product.

Recent Clinical Evidence

Tetran-Hydrocortison: Recent Clinical Evidence

Evidence for Use in Secondarily Infected Dermatoses

The primary evidence supporting the use of Tetran-Hydrocortison in skin conditions—such as eczema or dermatitis when a surface bacterial infection is present—comes from historically established controlled trials. This research was studied for its application in corticosteroid-responsive conditions characterized by fluctuating manifestations. Studies were designed to explore how symptoms change over short periods in adults and adolescents.

Researchers monitored outcomes related to physical discomfort, including the severity of itching (pruritus) and objective measurements of redness (erythema) and swelling. Findings describe measured patterns, such as short-term patterns observed in lesion severity scores and subjective discomfort, that were documented in some studies. This evidence contributes to the broader evidence landscape for describing the context of use in dual-pathology skin conditions.

Evidence for Post-Surgical Complication Prevention (Procedural Use)

Research has explored a highly specific, procedural use of the ointment following certain surgical tooth extractions in adult patients. This evidence, derived from small-scale comparative or observational studies, reflects a specialized, non-standard application.

Research examined outcomes related to post-operative events, specifically the incidence of Alveolar Osteitis (Dry Socket) and the measurement of post-operative pain intensity. Studies monitored data related to measured post-operative pain levels. The research base provides limited evidence due to the nature and size of the trials, which suggests certainty remains low for this context.

Research Gaps and Areas of Uncertainty

The majority of evidence is relevant only for short-term treatment of 7 to 14 days. Long-term effects and durability of response are not fully established, and evidence is limited for long-term outcomes. Furthermore, data for certain patient groups, such as the very young or older adults, remain insufficient. Overall evidence quality varies across studies, and comparative evidence against many newer treatments is lacking.

Key Studies & References MedlinePlus Drug Information: Hydrocortisone Topical (Contextual basis for corticosteroid component's class/mechanism)

How should Tetran-Hydrocortison be stored and disposed of?

The storage and disposal of Tetran-Hydrocortison (Oxytetracycline/Hydrocortisone combination) must adhere strictly to official regulatory requirements to ensure product stability and safety.

Official Storage Requirements

Element Requirement
Temperature Constraint Store the medicine below 25 C and protect from freezing.
Container Integrity The container must be kept tightly closed when not in use.
Shelf-Life Do not use the medicine after the labeled expiry date.

The regulatory label mandates that the medicine be kept out of the reach and sight of children.

Official Disposal Rules

Expired or unused Tetran-Hydrocortison must not be disposed of via wastewater or standard household waste. Patients are instructed to return the product to a pharmacist for proper, regulated disposal, which helps protect the environment from pharmaceutical contaminants.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

flagHungary

Equivalent of Tetran-Hydrocortison found in:

A-Z Index: